News

Exelixis delivers a strong Q1 performance with raised 2025 guidance, robust Cabometyx sales, and share buybacks. Read the ...
Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ETCompany ParticipantsTara Brady - Interim CFOShantanu Gaur ...